Oppenheimer raised its price target on Chemed (NYSE: CHE) to $340.00 (from $315.00) while maintaining a Outperform rating.Analyst Michael Wiederhorn ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE